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INTRODUCTION AND OBJECTIVES:
To compare the rate of hospital based outcomes including 30-day readmission rates, perioperative mortality, and length of stay (LOS) in patients with urologic malignancies who underwent surgery as part of treatment in academic and community hospitals METHODS: We retrospectively reviewed the Vizient CDB (Irving, Texas) from September 2014 to December 2017. Vizient includes approximately 97% of academic hospitals (AH) and more than 40 community hospitals (CH). This is a comparative database and measures performance within and between institutions. Data include patient demographics, readmission rates, costs, LOS, case mix index (CMI) and mortality. Patients aged ! 18 were included and ICD-9 codes were used to identify patients with urologic malignancies who underwent surgical treatment. Chi square and student t-tests were used to compare categorical and continuous variables, respectively RESULTS: We identified a total of 37,628 cases. There were 33,290 (88%) procedures performed in AH and 4,330 (12%) in CH. These included prostatectomy (18,540), radical nephrectomy (rNx) 8,059, partial nephrectomy (pNx) (5,287), radical cystectomy (4,421), radical nephroureterectomy (rNu) (1,006), and partial cystectomy (321). There were no significant differences in 30-day readmission rates or mortality for any procedure between academic and community hospitals (Table 1) , p> 0.05 for all. LOS was significantly lower for radical cystectomy and prostatectomy in AH (P<0.01 for both) and lower for rNx in CH (p[0.03). Academic hospitals had a significantly lower amount of partial cystectomies performed when compared to community centers (6.2% vs 16.2% P<0.001), and a similar number of partial nephrectomies performed (39.8% vs 38.0%, P[0.2). The mean direct cost for index admission was significantly higher in AH for rNx, pNx, rNu, and prostatectomy. Case complexity measured using the CMI was similar between the community and academic hospitals CONCLUSIONS: The Vizient CDB provides a novel resource for observational data at US hospitals. Despite academic and community hospitals having similar case complexity, direct costs were lower in community hospitals without an associated increase in readmission rates or deaths. The only clinically significant difference in length of stay was shorter stays for cystectomy in academic centers Source of Funding: None
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INTRODUCTION AND OBJECTIVES:
The Acute Care Surgery model is quickly becoming the standard for delivering urgent surgical care across North America. While this model has gained favour in other surgical fields, it has yet to be adopted in urology practice. We implemented an Acute Care Urology (ACU) model at a large Canadian community hospital to determine the measurable impacts on safe and timely care of patients with renal colic.
METHODS: In July 2016, we adopted the intervention of an ACU model through the addition of an ACU surgeon, creation of a rapid referral clinic dedicated to emergency department (ED) patient referrals, and enhanced use of daytime OR blocks. We conducted a manual chart review of 579 patients presenting to the ED with a complaint of renal colic. Patient data was collected in two separate time periods to analyze trends before implementation of the ACU model (pre-intervention, September -November 2015), to examine the model's impact (postintervention, September -November 2016). Secondary methods of evaluation included a survey of 20 ED physicians to capture subjective feedback through Likert scale data.
RESULTS: Of the evaluated 579 patients with a complaint of renal colic,194 patients were discharged from ED with an diagnosis of obstructing kidney stone and were referred to urology for outpatient care. The ED-to-clinic time was significantly lower for those in the ACU model (p <0.001). The mean time to clinic was 15.76 days (SD[15.47, range 1-93) pre-intervention versus 4.17 days (SD[2.33, range[ 1-12) post-intervention. Furthermore, the ACU clinic allowed significantly more patients to be referred for outpatient care (p [ 0.0004). There was also higher likelihood that patients would successfully obtain an appointment following referral (p [ 0.0055). Decreasing trends were shown in mean ED wait time, time from surgical assessment to procedure, and percentage of after-hours surgeries.Results of the qualitative survey were overwhelmingly positive. All 20 surveyed ED physicians were more confident that outpatients would be seen in a timely manner (85% strongly agree, 15% agree). Qualitative feedback included the belief that follow-up is more accessible, that ED physicians are less likely to page the oncall urologist, and that they are able to discharge patients sooner. Overall satisfaction with the ACU model was 95%, and all believe there has been a positive impact on patient care.
CONCLUSIONS: The ACU model for patients with renal colic may be beneficial in reducing ED-to-clinic time, ensuring proper followup after ED diagnosis, and improving patient care within the ED. Little is currently known about the association between cancer center status or integrated delivery system status and quality outcomes for patients with urological malignancies at the end of life.
METHODS: We used Surveillance, Epidemiology and End Results registry data linked with Medicare claims to evaluate quality for patients who died from bladder, kidney or prostate cancer and were diagnosed from 2008 through 2013. Patients were categorized as receiving the majority of their care in an integrated delivery system, certified cancer center, health system that was both or neither. We evaluated adherence to seven nationally endorsed end of life quality measures using generalized linear models and compared quality across health system characteristics.
RESULTS: Among 11,703 beneficiaries who died from prostate, kidney or bladder cancer during the study interval, we identified minimal differences in quality measure performance for patients treated in health systems regardless of integration and/or cancer focus (Figure) .
